Skip to content

NSRX NASUS PHARMA LTD

Follow

ORD SHS (common), issuer CIK 2029039

9 managers (9 13F filers) reported a position in NSRX shares at 2026-03-31, 2,174,274 shares in all. 7 filers opened a position and 0 filers sold out during the quarter.

Managers
9
13F filers
9
New
7
Added
1
Reduced
0
Sold out
0
Shares held by filers
2,174,274

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Balyasny Asset Management L.P.in group Balyasny Asset Management898,473$1.99M<0.01%new13F-HRTimelineGroup
Cable Car Capital, LP601,998$1.34M0.46%new13F-HRTimeline
Velan Capital Investment Management LP359,390$798K0.5%new13F-HRTimeline
Hudson Bay Capital Management LPin group Hudson Bay Capital Management…134,771$299K<0.01%new13F-HRTimelineGroup
Bleichroeder LP89,848$199K0.03%new13F-HRTimeline
Empery Asset Management, LP45,803$102K0.12%new13F-HRTimeline
HRT FINANCIAL LP38,897$86K<0.01%new13F-HRTimeline
UBS Group AGin group UBS Group AG3,094$6.87K<0.01%+2,71613F-HRTimelineGroup
MORGAN STANLEYin group MORGAN STANLEY2,000$4.44K<0.01%013F-HRTimelineGroup